Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|March 18, 2026
Relevance and limitations of clinical follow-up in a pharmacokinetic study on direct oral anticoagulantsJean Terrier, Pauline Gosselin, Christophe Combescure, et al.
Clinical Pharmacology and Therapeutics|May 20, 2022
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure SimulationJean Terrier, Frédéric Gaspar, Monia Guidi, et al.
Frontiers in Pharmacology|April 18, 2024
Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in SwitzerlandClaire Coumau, Frederic Gaspar, Jean Terrier, et al.
The Journal of Sexual Medicine|March 13, 2021
Predictors of Depression in Men With Peyronie's Disease Seeking EvaluationNahid Punjani, Bruno Nascimento, Carolyn Salter, et al.
The Journal of Sexual Medicine|July 6, 2021
Predictors of Pursuing Intralesional Xiaflex in Peyronie's Disease PatientsNahid Punjani, Bruno Nascimento, Carolyn Salter, et al.
Clinical Pharmacokinetics|January 11, 2025
Improving Understanding of Fexofenadine Pharmacokinetics to Assess Pgp Phenotypic Activity in Older Adult Patients Using Population Pharmacokinetic ModelingFrédéric Gaspar, Celestin Jacost-Descombes, Pauline Gosselin, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2021
Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with LetermovirJean Terrier, Marie-Céline Zanella, Stavroula Masouridi-Levrat, et al.
Clinical Pharmacology and Therapeutics|September 2, 2021
Impact of SARS-CoV-2 Infection (COVID-19) on Cytochromes P450 Activity Assessed by the Geneva CocktailCamille Lenoir, Jean Terrier, Yvonne Gloor, et al.
Journal of Personalized Medicine|April 23, 2022
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World SettingCamille Lenoir, Jean Terrier, Yvonne Gloor, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 5, 2023
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed sideJean Terrier, Frédéric Gaspar, Pauline Gosselin, et al.
Pageof 3